Metabolic Agents

Multum Therapeutic Class Comparison, United States, 2024

Total Prescriptions in (2024)

Drug Name	Total Prescriptions (2024)	Percent Share
Atorvastatin	115,678,209	22.6%
Metformin	82,288,617	16.1%
Rosuvastatin	53,688,649	10.5%
Semaglutide	40,938,166	8%
Simvastatin	21,477,296	4.2%
Insulin Glargine	21,364,478	4.2%
Empagliflozin	20,797,026	4.1%
Tirzepatide	18,694,231	3.6%
Allopurinol	14,851,781	2.9%
Glipizide	12,809,578	2.5%
Pravastatin	11,270,968	2.2%
Ezetimibe	10,693,932	2.1%
Insulin Lispro	10,412,617	2%
Dulaglutide	9,211,040	1.8%
Insulin Aspart	8,979,716	1.8%
Alendronate	8,209,513	1.6%
Dapagliflozin	8,017,363	1.6%
Fenofibrate	7,367,061	1.4%
Insulin Degludec	5,466,073	1.1%
Sitagliptin	5,147,491	1%
Glimepiride	5,109,702	1%
Pioglitazone	4,851,830	0.9%
Evolocumab	3,521,049	0.7%
Lovastatin	3,113,074	0.6%
Colchicine	2,253,946	0.4%
Insulin Human; Insulin Isophane Human	2,227,310	0.4%
Insulin Isophane	1,314,871	0.3%
Insulin Detemir	1,310,971	0.3%
Liraglutide	826,310	0.2%
Niacin	382,100	0.1%
Red Yeast Rice	6,733	0%

Total Prescriptions by Drug Over Time

Drug Class Prescribing Trends Over Time

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2014-2024. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 2026.08. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).

Search

Mailing List

Get Email Updates

New and Popular

Open Menu

Cite This Page

Show AMA citation

Disclaimer - Privacy Policy - Contact Us
Updated Sep 12, 2021

Top